1 not yet recruiting, 1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow 5 FU continuous: new trials by email Literature Review of 5 FU continuous trials Research Report on 5 FU continuous
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Second-line Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Fruquintinib Versus Doublet Chemotherapy (FOLFOX or FOLFIRI) Plus Bevacizumab in Metastatic Colorectal Cancer Oxaliplatin intravenous, 5 FU bolus, Folinic acid - Metastatic Colorectal Carcinoma (mCRC) | Phase 2 | Not yet recruiting | Federation Francophone de Cancerologie Digestive | 74 | 2025-12-31 | 2025-09-08 |
| Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver Oxaliplatin intravenous, 5 FU bolus, Folinic acid - Colorectal Neoplasms | Phase 3 | Recruiting | Federation Francophone de Cancerologie Digestive | 348 | 2016-12-01 | 2025-07-09 |
Colorectal Neoplasms (2) · Neoplasm Metastasis (1) · Neoplasms (1)
Federation Francophone de Cancerologie Digestive (2)
France (2) · Belgium (1)
2025 (1)